Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Non Operating Income (2018 - 2025)

Historic Non Operating Income for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $44000.0.

  • Viemed Healthcare's Non Operating Income fell 8405.8% to $44000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $279000.0, marking a year-over-year increase of 19721.25%. This contributed to the annual value of -$173000.0 for FY2024, which is 27653.06% down from last year.
  • Viemed Healthcare's Non Operating Income amounted to $44000.0 in Q3 2025, which was down 8405.8% from $72000.0 recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Non Operating Income registered a high of $1.5 million during Q4 2021, and its lowest value of -$563000.0 during Q2 2024.
  • Moreover, its 5-year median value for Non Operating Income was $57000.0 (2022), whereas its average is $139526.3.
  • In the last 5 years, Viemed Healthcare's Non Operating Income skyrocketed by 90181.82% in 2022 and then plummeted by 2825000.0% in 2024.
  • Over the past 5 years, Viemed Healthcare's Non Operating Income (Quarter) stood at $1.5 million in 2021, then tumbled by 82.56% to $268000.0 in 2022, then crashed by 109.7% to -$26000.0 in 2023, then surged by 438.46% to $88000.0 in 2024, then tumbled by 50.0% to $44000.0 in 2025.
  • Its Non Operating Income stands at $44000.0 for Q3 2025, versus $72000.0 for Q2 2025 and $75000.0 for Q1 2025.